...
首页> 外文期刊>Russian journal of bioorganic chemistry >Mechanism of the inhibitory effect of angiostatin on plasminogen activation by its physiologic activators
【24h】

Mechanism of the inhibitory effect of angiostatin on plasminogen activation by its physiologic activators

机译:血管抑素通过其生理激活因子抑制纤溶酶原激活的机制

获取原文
获取原文并翻译 | 示例
           

摘要

The influence of angiostatin K1-4.5, a fragment of the heavy chain of plasmin and a powerful inhibitor of angiogenesis, on kinetic parameters (k_ (Pg) and K_ (Pg)) of human Glu-plasminogen activation under the action of urokinase (uPA) not having affinity for fibrin and fibrin-specific tissue plasminogen activator (tPA) was investigated. Angiostatin does not affect on the k_ (Pg) value, but increases the value of K_ (Pg) plasminogen activation by urokinase. A decrease in the k Pg value and an increase in the K_(Pg) value were found for fibrin-stimulated plasminogen activation by tPA with increasing concentrations of angiostatin. The obtained results show that angiostatin is a competitive inhibitor of the uPA activator activity, while it inhibits the activator activity of tPA with a mixed type. Such an influence of angiostatin on the kinetic constants of the plasminogen activation by urokinase suggests that angiostatin dose-dependent manner replaces plasminogen in the binary enzyme-substrate complex uPA-Pg. In the case of fibrin-stimulated plasminogen activation by tPA, both zymogen and tPA are bound to fibrin with the formation of the effective triple tPA-Pg-fibrin complex. Angiostatin replaces plasminogen both from the fibrin surface and from the enzyme-substrate tPA-Pg complex, which leads to a decrease in k_(Pg) and an increase in K_(Pg) of the plasminogen activation. Inhibition constants by angiostatin (K_ i) of plasminogen-activator activities of uPA and tPA determined by the Dixon method were found to be 0.59 ± 0.04 and 0.12 ± 0.05 μM, respectively.
机译:纤溶酶重链片段和强大的血管生成抑制剂血管抑素K1-4.5对尿激酶(uPA)作用下人Glu-纤溶酶原激活的动力学参数(k_(Pg)和K_(Pg))的影响研究了对纤维蛋白和纤维蛋白特异性组织纤溶酶原激活剂(tPA)没有亲和力的物质。血管抑制素不影响k_(Pg)值,但会增加尿激酶激活K_(Pg)纤溶酶原的值。发现随着浓度增加的血管生成抑制素,tPA激活的血纤蛋白刺激的纤溶酶原激活,k Pg值降低,K_(Pg)值升高。获得的结果表明,血管抑制素是uPA活化剂活性的竞争性抑制剂,而它抑制了混合型tPA的活化剂活性。血管抑素对尿激酶激活纤溶酶原的动力学常数的这种影响表明,血管抑素的剂量依赖性方式替代了二元酶-底物复合物uPA-Pg中的纤溶酶原。在纤维蛋白刺激的纤溶酶原被tPA激活的情况下,酶原和tPA都与纤维蛋白结合,形成有效的三联tPA-Pg-纤维蛋白复合物。血管抑素从纤维蛋白表面和酶-底物tPA-Pg复合物中都替代了纤溶酶原,这导致纤溶酶原激活的k_(Pg)降低和K_(Pg)升高。用Dixon法测定的血管抑素(Ki)对uPA和tPA纤溶酶原激活物活性的抑制常数分别为0.59±0.04和0.12±0.05μM。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号